Puma Biotechnology's director Michael Patrick Miller sells 15,000 shares, impacting the company's equity structure. The pharmaceutical industry watches closely.
| Name | PUMA BIOTECHNOLOGY, INC. |
|---|---|
| CIK | 0001401667 |
| Tickers | PBYI |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 770683487 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (424) 248-6500 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Puma Biotechnology's director Michael Patrick Miller sells 15,000 shares, impacting the company's equity structure. The pharmaceutical industry watches closely.
Puma Biotechnology's Director Michael Patrick Miller sells 15,000 shares, valued at $121,457, reflecting ongoing market activity in the pharmaceutical sector.
Puma Biotechnology, Inc. announces its Q3 results, showcasing its commitment to cancer care innovation within the pharmaceutical preparations sector.
Puma Biotechnology announces third-quarter financial results, highlighting increased NERLYNX sales and raised net income guidance for 2026.
1127 filing rows loaded from submissions recent; extra archives: CIK0001401667-submissions-001.json (126 filings, 2007-09-14 to 2012-11-12).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000052388-26-000503 | 005-83367 | 261558759 | 34 | 14529 | |||
| 2026-11-13 | 4 | FORM 4 | 0001437749-26-036984 | 5311 | ||||||
| 2026-11-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007942 | 001-35703 | 261543227 | 33 | 4748 | |||
| 2026-11-09 | 10-Q | FORM 10-Q | 0001437749-26-035912 | 001-35703 | 261536520 | 34 | 9256972 | 1 | 1 | |
| 2026-11-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-035279 | 001-35703 | 261527492 | 34 | 473190 | 1 | 1 |
| 2026-10-06 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-114167 | 005-83367 | 261445326 | 34 | 10740 | |||
| 2026-09-16 | 4 | FORM 4 | 0001437749-26-030597 | 6006 | ||||||
| 2026-09-16 | 4 | FORM 4 | 0001437749-26-030593 | 8591 | ||||||
| 2026-09-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006918 | 001-35703 | 261376472 | 33 | 5049 | |||
| 2026-09-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006917 | 001-35703 | 261376461 | 33 | 4551 | |||
| 2026-08-06 | 10-Q | FORM 10-Q | 0001437749-26-026311 | 001-35703 | 261249925 | 34 | 9085516 | 1 | 1 | |
| 2026-08-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-026282 | 001-35703 | 261249426 | 34 | 435313 | 1 | 1 |
| 2026-07-08 | 4 | FORM 4 | 0001437749-26-023079 | 4759 | ||||||
| 2026-07-08 | 4 | FORM 4 | 0001437749-26-023078 | 4801 | ||||||
| 2026-07-08 | 4 | FORM 4 | 0001437749-26-023077 | 4709 | ||||||
| 2026-07-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005126 | 001-35703 | 261156689 | 33 | 4612 | |||
| 2026-07-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005123 | 001-35703 | 261156618 | 33 | 4581 | |||
| 2026-07-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005121 | 001-35703 | 261156550 | 33 | 4592 | |||
| 2026-06-16 | 8-K | FORM 8-K | 5.07 | 0001437749-26-020793 | 001-35703 | 261094636 | 34 | 193251 | 1 | 1 |
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020709 | 8233 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020708 | 6823 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020706 | 6862 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020705 | 5124 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020704 | 6854 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020703 | 6859 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020702 | 4800 | ||||||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004590 | 001-35703 | 261085327 | 33 | 4560 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004589 | 001-35703 | 261085323 | 33 | 4550 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004588 | 001-35703 | 261085318 | 33 | 4553 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004586 | 001-35703 | 261085293 | 33 | 4512 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004584 | 001-35703 | 261085206 | 33 | 4553 | |||
| 2026-05-07 | 10-Q | FORM 10-Q | 0001437749-26-015633 | 001-35703 | 26954309 | 34 | 7440821 | 1 | 1 | |
| 2026-05-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-015621 | 001-35703 | 26954148 | 34 | 337624 | 1 | 1 |
| 2026-04-28 | DEFA14A | FORM DEFA14A | 0001437749-26-013674 | 001-35703 | 26908086 | 34 | 1101671 | |||
| 2026-04-28 | ARS | FORM ARS | 0001437749-26-013673 | 001-35703 | 26908066 | 34 | 18269268 | |||
| 2026-04-28 | DEF 14A | FORM DEF 14A | 0001437749-26-013671 | 001-35703 | 26908019 | 34 | 2958667 | 1 | 1 | |
| 2026-04-07 | PRE 14A | FORM PRE 14A | 0001437749-26-011631 | 001-35703 | 26845692 | 34 | 2952735 | 1 | 1 | |
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002190 | 005-83367 | 26803235 | 34 | 7295 | |||
| 2026-02-26 | 10-K | FORM 10-K | 0001437749-26-005891 | 001-35703 | 26689671 | 34 | 11203072 | 1 | 1 | |
| 2026-02-26 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-005869 | 001-35703 | 26688388 | 34 | 410464 | 1 | 1 |
| 2026-02-20 | 4 | FORM 4 | 0001437749-26-004948 | 7410 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001437749-26-004947 | 7353 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001437749-26-004946 | 7262 | ||||||
| 2026-01-08 | 4 | FORM 4 | 0001437749-26-000924 | 6039 | ||||||
| 2026-01-08 | 4 | FORM 4 | 0001437749-26-000922 | 6092 | ||||||
| 2026-01-08 | 4 | FORM 4 | 0001437749-26-000921 | 6000 | ||||||
| 2026-01-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000194 | 001-35703 | 26516015 | 33 | 5286 | |||
| 2026-01-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000193 | 001-35703 | 26515978 | 33 | 5266 | |||
| 2026-01-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000192 | 001-35703 | 26515969 | 33 | 5275 | |||
| 2026-01-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000171 | 001-35703 | 26512483 | 33 | 4634 | |||
| 2026-01-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000167 | 001-35703 | 26512399 | 33 | 4629 | |||
| 2026-01-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000165 | 001-35703 | 26512374 | 33 | 4642 | |||
| 2025-11-13 | 4 | FORM 4 | 0001437749-25-034874 | 5203 | ||||||
| 2025-11-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006907 | 001-35703 | 251469280 | 33 | 4782 | |||
| 2025-11-06 | 10-Q | FORM 10-Q | 0001437749-25-033633 | 001-35703 | 251459141 | 34 | 8238434 | 1 | 1 | |
| 2025-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-033604 | 001-35703 | 251458516 | 34 | 406778 | 1 | 1 |
| 2025-08-07 | 10-Q | FORM 10-Q | 0001437749-25-025470 | 001-35703 | 251194879 | 34 | 8253604 | 1 | 1 | |
| 2025-08-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-025463 | 001-35703 | 251194718 | 34 | 412156 | 1 | 1 |
| 2025-08-07 | 10-Q/A | FORM 10-Q/A | 0001437749-25-025214 | 001-35703 | 251191306 | 34 | 242544 | 1 | 1 | |
| 2025-07-22 | 4 | FORM 4 | 0001437749-25-023268 | 5011 | ||||||
| 2025-07-18 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004647 | 001-35703 | 251134689 | 33 | 5193 | |||
| 2025-07-10 | 4 | FORM 4 | 0001437749-25-022551 | 6001 | ||||||
| 2025-07-10 | 4 | FORM 4 | 0001437749-25-022549 | 6093 | ||||||
| 2025-07-10 | 4 | FORM 4 | 0001437749-25-022547 | 6040 | ||||||
| 2025-07-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004521 | 001-35703 | 251114064 | 33 | 5276 | |||
| 2025-07-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004519 | 001-35703 | 251113964 | 33 | 5289 | |||
| 2025-07-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004517 | 001-35703 | 251113873 | 33 | 5267 | |||
| 2025-07-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004506 | 001-35703 | 251111453 | 33 | 4650 | |||
| 2025-07-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004505 | 001-35703 | 251111435 | 33 | 4630 | |||
| 2025-07-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004503 | 001-35703 | 251111341 | 33 | 4630 | |||
| 2025-06-24 | 8-K | FORM 8-K | 5.03,9.01 | 0001437749-25-021153 | 001-35703 | 251069010 | 34 | 346419 | 1 | 1 |
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020721 | 6424 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020719 | 5010 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020717 | 5066 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020715 | 4886 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020713 | 5047 | ||||||
| 2025-06-17 | 4 | FORM 4 | 0001437749-25-020711 | 5010 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020363 | 4941 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020362 | 4749 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020361 | 4569 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020360 | 4730 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020359 | 4695 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020358 | 6107 | ||||||
| 2025-06-13 | 4 | FORM 4 | 0001437749-25-020357 | 4693 | ||||||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004074 | 001-35703 | 251046753 | 33 | 4585 | |||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004071 | 001-35703 | 251046651 | 33 | 4602 | |||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004070 | 001-35703 | 251046645 | 33 | 4583 | |||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004069 | 001-35703 | 251046613 | 33 | 4552 | |||
| 2025-06-13 | 8-K | FORM 8-K | 5.07 | 0001437749-25-020321 | 001-35703 | 251046568 | 34 | 176956 | 1 | 1 |
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004068 | 001-35703 | 251046566 | 33 | 4542 | |||
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004067 | 001-35703 | 251046416 | 33 | 4419 | |||
| 2025-05-21 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-003393 | 001-35703 | 25972841 | 33 | 4490 | |||
| 2025-05-09 | 8-K | FORM 8-K | 5.02 | 0001437749-25-015648 | 001-35703 | 25928563 | 34 | 161167 | 1 | 1 |
| 2025-05-08 | 10-Q | FORM 10-Q | 0001437749-25-015533 | 001-35703 | 25926984 | 34 | 7466137 | 1 | 1 | |
| 2025-05-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-015514 | 001-35703 | 25926534 | 34 | 335505 | 1 | 1 |
| 2025-04-28 | DEFA14A | FORM DEFA14A | 0001437749-25-013339 | 001-35703 | 25880673 | 34 | 420271 | |||
| 2025-04-28 | ARS | ARS | 0001437749-25-013338 | 001-35703 | 25880653 | 34 | 12351831 | |||
| 2025-04-28 | DEF 14A | FORM DEF 14A | 0001437749-25-013337 | 001-35703 | 25880634 | 34 | 2958658 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000642 | 005-83367 | 25844572 | 34 | 10878 | |||
| 2025-02-27 | 10-K | FORM 10-K | 0001437749-25-005496 | 001-35703 | 25679932 | 34 | 10620239 | 1 | 1 | |
| 2025-02-27 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-005477 | 001-35703 | 25679246 | 34 | 391968 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-25-000007 | 005-83367 | 25625560 | 34 | 12219 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-003981 | 005-83367 | 25624969 | 34 | 37675 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001654954-25-001504 | 005-83367 | 25623484 | 34 | 12001 | |||
| 2025-02-11 | 4 | FORM 4 | 0001437749-25-003461 | 7209 | ||||||
| 2025-02-11 | 4 | FORM 4 | 0001437749-25-003459 | 7224 | ||||||
| 2025-02-11 | 4 | FORM 4 | 0001437749-25-003456 | 7301 | ||||||
| 2025-02-11 | 4 | FORM 4 | 0001437749-25-003454 | 7297 | ||||||
| 2025-02-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-008607 | 005-83367 | 25582406 | 34 | 18447 | |||
| 2025-01-03 | 4 | FORM 4 | 0001437749-25-000365 | 5149 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001437749-25-000363 | 5163 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001437749-25-000361 | 5240 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001437749-25-000359 | 5185 | ||||||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-25-000004 | 001-35703 | 25503575 | 33 | 5179 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-25-000003 | 001-35703 | 25503574 | 33 | 5188 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-25-000002 | 001-35703 | 25503572 | 33 | 5171 | |||
| 2025-01-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-25-000001 | 001-35703 | 25503567 | 33 | 5850 | |||
| 2024-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-24-000040 | 005-83367 | 241459223 | 34 | 12364 | |||
| 2024-11-08 | SC 13G | us74587v1070_110824.txt | 0002012383-24-004166 | 005-83367 | 241442177 | 34 | 13824 | |||
| 2024-11-07 | 10-Q | FORM 10-Q | 0001437749-24-033955 | 001-35703 | 241436619 | 34 | 7879683 | 1 | 1 | |
| 2024-11-07 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-033929 | 001-35703 | 241435918 | 34 | 393503 | 1 | 1 |
| 2024-10-22 | SC 13G | us74587v1070_102224.txt | 0002012383-24-001266 | 005-83367 | 241386101 | 34 | 13812 | |||
| 2024-09-16 | 8-K | FORM 8-K | 8.01 | 0001437749-24-029206 | 001-35703 | 241299481 | 34 | 173010 | 1 | 1 |
| 2024-08-27 | S-8 | FORM S-8 | 0001437749-24-027862 | 333-281803 | 241249906 | 33 | 104161 | |||
| 2024-08-15 | 8-K | FORM 8-K | 8.01 | 0001437749-24-026953 | 001-35703 | 241210798 | 34 | 170463 | 1 | 1 |
| 2024-08-13 | 4 | FORM 4 | 0001437749-24-026536 | 5357 | ||||||
| 2024-08-12 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000426 | 001-35703 | 241198523 | 33 | 5304 | |||
| 2024-08-07 | 8-K | FORM 8-K | 8.01 | 0001437749-24-025027 | 001-35703 | 241181755 | 34 | 165171 | 1 | 1 |
| 2024-08-01 | 10-Q | FORM 10-Q | 0001437749-24-024309 | 001-35703 | 241167416 | 34 | 7809445 | 1 | 1 | |
| 2024-08-01 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-024297 | 001-35703 | 241166972 | 34 | 386442 | 1 | 1 |
| 2024-07-18 | 4 | FORM 4 | 0001437749-24-023022 | 5152 | ||||||
| 2024-07-18 | 4 | FORM 4 | 0001437749-24-023020 | 5167 | ||||||
| 2024-07-18 | 4 | FORM 4 | 0001437749-24-023017 | 5244 | ||||||
| 2024-07-18 | 4 | FORM 4 | 0001437749-24-023014 | 5189 | ||||||
| 2024-07-17 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000402 | 001-35703 | 241123520 | 33 | 5269 | |||
| 2024-07-17 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000401 | 001-35703 | 241123516 | 33 | 5283 | |||
| 2024-07-17 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000400 | 001-35703 | 241123514 | 33 | 5260 | |||
| 2024-07-17 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000399 | 001-35703 | 241123512 | 33 | 5352 | |||
| 2024-07-02 | 4 | FORM 4 | 0001437749-24-022067 | 5151 | ||||||
| 2024-07-02 | 4 | FORM 4 | 0001437749-24-022065 | 5166 | ||||||
| 2024-07-02 | 4 | FORM 4 | 0001437749-24-022063 | 5243 | ||||||
| 2024-07-02 | 4 | FORM 4 | 0001437749-24-022061 | 5188 | ||||||
| 2024-07-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000388 | 001-35703 | 241098014 | 33 | 4591 | |||
| 2024-07-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000387 | 001-35703 | 241098011 | 33 | 4601 | |||
| 2024-07-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000386 | 001-35703 | 241097997 | 33 | 4584 | |||
| 2024-07-02 | 144 | xsl144X01/primary_doc.xml | 0001610717-24-000385 | 001-35703 | 241097992 | 33 | 5260 | |||
| 2024-06-24 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001437749-24-021086 | 001-35703 | 241064499 | 34 | 207110 | 1 | 1 |
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021024 | 6114 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021022 | 4701 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021020 | 4756 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021018 | 4948 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021016 | 4576 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021014 | 4737 | ||||||
| 2024-06-21 | 4 | FORM 4 | 0001437749-24-021012 | 4700 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001437749-24-020574 | 6457 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001437749-24-020572 | 5045 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001437749-24-020570 | 5097 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001437749-24-020568 | 4921 | ||||||
| 2024-06-17 | 4 | FORM 4 | 0001437749-24-020566 | 5082 | ||||||
| 2024-06-13 | 144 | xsl144X01/primary_doc.xml | 0002001666-24-000010 | 001-35703 | 241042911 | 33 | 4587 | |||
| 2024-06-13 | 144 | xsl144X01/primary_doc.xml | 0002001666-24-000009 | 001-35703 | 241042906 | 33 | 4545 | |||
| 2024-06-13 | 144 | xsl144X01/primary_doc.xml | 0002001666-24-000008 | 001-35703 | 241042904 | 33 | 4601 | |||
| 2024-06-13 | 144 | xsl144X01/primary_doc.xml | 0002001666-24-000007 | 001-35703 | 241042902 | 33 | 4421 | |||
| 2024-06-13 | 144 | xsl144X01/primary_doc.xml | 0002001666-24-000006 | 001-35703 | 241042900 | 33 | 4582 | |||
| 2024-05-17 | 8-K | FORM 8-K | 8.01 | 0001437749-24-017504 | 001-35703 | 24960589 | 34 | 162736 | 1 | 1 |
| 2024-05-02 | 10-Q | FORM 10-Q | 0001437749-24-014395 | 001-35703 | 24909193 | 34 | 7143267 | 1 | 1 | |
| 2024-05-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-014382 | 001-35703 | 24908578 | 34 | 326953 | 1 | 1 |
| 2024-04-26 | DEFA14A | FORM DEFA14A | 0001437749-24-013311 | 001-35703 | 24878919 | 34 | 396963 | |||
| 2024-04-26 | ARS | pbyiars.pdf | 0001437749-24-013310 | 001-35703 | 24878913 | 34 | 7964088 | |||
| 2024-04-26 | DEF 14A | FORM DEF 14A | 0001437749-24-013309 | 001-35703 | 24878909 | 34 | 3725835 | 1 | 1 | |
| 2024-03-29 | SC 13G | SC 13G | 0001193125-24-081657 | 005-83367 | 24802501 | 34 | 322559 | |||
| 2024-03-19 | 4 | FORM 4 | 0001437749-24-008575 | 7556 | ||||||
| 2024-03-19 | 8-K | FORM 8-K | 8.01 | 0001437749-24-008508 | 001-35703 | 24763033 | 34 | 164700 | 1 | 1 |
| 2024-02-29 | 10-K | FORM 10-K | 0001437749-24-006121 | 001-35703 | 24704525 | 34 | 10323059 | 1 | 1 | |
| 2024-02-29 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-006099 | 001-35703 | 24703867 | 34 | 391065 | 1 | 1 |
| 2024-02-14 | 4 | FORM 4 | 0001437749-24-004218 | 7198 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001437749-24-004216 | 7209 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001437749-24-004214 | 7224 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001437749-24-004211 | 7292 | ||||||
| 2024-02-14 | 4 | FORM 4 | 0001437749-24-004207 | 7301 | ||||||
| 2024-02-14 | SC 13G/A | PRIMARY DOCUMENT | 0001654954-24-001699 | 005-83367 | 24632523 | 34 | 67472 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021773 | 005-83367 | 24629312 | 34 | 13185 | |||
| 2024-02-06 | SC 13G/A | PUMA BIOTECHNOLOGY, INC. | 0000902664-24-001097 | 005-83367 | 24600039 | 34 | 104987 | |||
| 2024-01-30 | SC 13G/A | PBYI_SC13GA2_2024.htm | 0001273087-24-000028 | 005-83367 | 24578215 | 34 | 96011 | |||
| 2024-01-18 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-24-001581 | 001-35703 | 24540219 | 34 | 11282761 | 1 | 1 |
| 2024-01-10 | 4 | FORM 4 | 0001437749-24-001115 | 5140 | ||||||
| 2024-01-10 | 144/A | xsl144X01/primary_doc.xml | 0001842612-24-000003 | 001-35703 | 24527020 | 33 | 5989 | |||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000776 | 5143 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000773 | 5170 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000770 | 12044 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000768 | 5156 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000765 | 5247 | ||||||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0002006196-24-000006 | 001-35703 | 24509630 | 33 | 5767 | |||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0002006196-24-000005 | 001-35703 | 24509627 | 33 | 5777 | |||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0002006196-24-000004 | 001-35703 | 24509625 | 33 | 5166 | |||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0002006196-24-000003 | 001-35703 | 24509621 | 33 | 5759 | |||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0002006196-24-000002 | 001-35703 | 24509612 | 33 | 5782 | |||
| 2023-11-09 | 4 | FORM 4 | 0001437749-23-031275 | 5056 | ||||||
| 2023-11-07 | 144 | xsl144X01/primary_doc.xml | 0001967196-23-000001 | 001-35703 | 231385671 | 33 | 5222 | |||
| 2023-11-02 | 10-Q | FORM 10-Q | 0001437749-23-030028 | 001-35703 | 231373109 | 34 | 7782471 | 1 | 1 | |
| 2023-11-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-23-030014 | 001-35703 | 231372614 | 34 | 382572 | 1 | 1 |
| 2023-09-26 | 8-K | FORM 8-K | 7.01 | 0001437749-23-026766 | 001-35703 | 231280570 | 34 | 155220 | 1 | 1 |
| 2023-09-01 | SC 13G | PUMA BIOTECHNOLOGY, INC. | 0000902664-23-004670 | 005-83367 | 231230993 | 34 | 109172 | |||
| 2023-08-18 | 8-K | FORM 8-K | 5.03,9.01 | 0001437749-23-024168 | 001-35703 | 231186075 | 34 | 360241 | 1 | 1 |
| 2023-08-03 | 10-Q | FORM 10-Q | 0001437749-23-021972 | 001-35703 | 231140825 | 34 | 7783738 | 1 | 1 | |
| 2023-08-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-23-021937 | 001-35703 | 231140099 | 34 | 356497 | 1 | 1 |
| 2023-07-06 | 4 | FORM 4 | 0001437749-23-019528 | 5059 | ||||||
| 2023-07-06 | 4 | FORM 4 | 0001437749-23-019525 | 5071 | ||||||
| 2023-07-06 | 4 | FORM 4 | 0001437749-23-019523 | 5086 | ||||||
| 2023-07-06 | 4 | FORM 4 | 0001437749-23-019521 | 5162 | ||||||
| 2023-07-06 | 4 | FORM 4 | 0001437749-23-019519 | 12049 | ||||||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001230439-23-000011 | 001-35703 | 231066362 | 33 | 5106 | |||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001230439-23-000010 | 001-35703 | 231066359 | 33 | 369536 | |||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001230439-23-000009 | 001-35703 | 231066349 | 33 | 312765 | |||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001230439-23-000008 | 001-35703 | 231066345 | 33 | 549912 | |||
| 2023-07-03 | 144 | xsl144X01/primary_doc.xml | 0001230439-23-000007 | 001-35703 | 231066336 | 33 | 1436897 | |||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017612 | 14726 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017610 | 13331 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017608 | 13815 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017606 | 13914 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017604 | 18190 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017594 | 6904 | ||||||
| 2023-06-15 | 4 | FORM 4 | 0001437749-23-017590 | 4618 | ||||||
| 2023-06-15 | 8-K | FORM 8-K | 5.07 | 0001437749-23-017581 | 001-35703 | 231018362 | 34 | 175504 | 1 | 1 |
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000012 | 001-35703 | 231012828 | 33 | 648836 | |||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000011 | 001-35703 | 231012823 | 33 | 419596 | |||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000010 | 001-35703 | 231012820 | 33 | 3543740 | |||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000009 | 001-35703 | 231012805 | 33 | 310212 | |||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000008 | 001-35703 | 231012804 | 33 | 318756 | |||
| 2023-06-13 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000007 | 001-35703 | 231012803 | 33 | 307575 | |||
| 2023-06-06 | 4 | FORM 4 | 0001437749-23-016759 | 5058 | ||||||
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001842612-23-000003 | 001-35703 | 23990702 | 33 | 870372 | |||
| 2023-05-04 | 10-Q | FORM 10-Q | 0001437749-23-012589 | 001-35703 | 23889525 | 34 | 7019579 | 1 | 1 | |
| 2023-05-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-23-012576 | 001-35703 | 23888991 | 34 | 309503 | 1 | 1 |
| 2023-04-28 | DEFA14A | FORM DEFA14A | 0001437749-23-011502 | 001-35703 | 23860424 | 34 | 582456 | |||
| 2023-04-28 | ARS | formars.pdf | 0001437749-23-011501 | 001-35703 | 23860396 | 34 | 19141837 | |||
| 2023-04-28 | DEF 14A | FORM DEF 14A | 0001437749-23-011500 | 001-35703 | 23860354 | 34 | 3060231 | 1 | 1 | |
| 2023-03-02 | 10-K | FORM 10-K | 0001437749-23-005233 | 001-35703 | 23699732 | 34 | 10639965 | 1 | 1 | |
| 2023-03-02 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-23-005220 | 001-35703 | 23699029 | 34 | 362869 | 1 | 1 |
| 2023-02-14 | 4 | FORM 4 | 0001437749-23-003388 | 7084 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001437749-23-003382 | 7095 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001437749-23-003379 | 7110 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001437749-23-003375 | 7187 | ||||||
| 2023-02-14 | 4 | FORM 4 | 0001437749-23-003371 | 7140 | ||||||
| 2023-02-14 | SC 13G/A | PRIMARY DOCUMENT | 0001654954-23-001644 | 005-83367 | 23622861 | 34 | 67284 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016787 | 005-83367 | 23604062 | 34 | 13103 | |||
| 2023-02-07 | SC 13G/A | PUMA_BIO.txt | 0000769993-23-000080 | 005-83367 | 23595541 | 34 | 23717 | |||
| 2023-01-19 | SC 13G/A | PBYI_SC13GA1_2023.htm | 0001273087-23-000041 | 005-83367 | 23537643 | 34 | 81606 | |||
| 2023-01-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-23-000699 | 001-35703 | 23516858 | 34 | 15475830 | 1 | 1 |
| 2023-01-05 | 4 | FORM 4 | 0001437749-23-000552 | 5146 | ||||||
| 2023-01-05 | 4 | FORM 4 | 0001437749-23-000547 | 5159 | ||||||
| 2023-01-05 | 4 | FORM 4 | 0001437749-23-000534 | 5172 | ||||||
| 2023-01-05 | 4 | FORM 4 | 0001437749-23-000521 | 5249 | ||||||
| 2023-01-05 | 4 | FORM 4 | 0001437749-23-000512 | 5157 | ||||||
| 2022-12-16 | 8-K | FORM 8-K | 8.01 | 0001437749-22-029261 | 001-35703 | 221468147 | 34 | 155434 | 1 | 1 |
| 2022-12-13 | SC 13D/A | SCHEDULE 13D/A | 0001437749-22-028938 | 005-83367 | 221458190 | 34 | 47455 | |||
| 2022-12-13 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001437749-22-028937 | 001-35703 | 221458186 | 34 | 359224 | 1 | 1 |
| 2022-12-12 | 4 | FORM 4 | 0001437749-22-028940 | 4668 | ||||||
| 2022-12-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-22-028774 | 001-35703 | 221453700 | 34 | 367911 | 1 | 1 |
| 2022-12-08 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-22-028687 | 001-35703 | 221451220 | 34 | 637564 | 1 | 1 |
| 2022-12-06 | 4 | FORM 4 | 0001437749-22-028564 | 5158 | ||||||
| 2022-12-06 | 4 | FORM 4 | 0001437749-22-028559 | 5250 | ||||||
| 2022-12-06 | 4 | FORM 4 | 0001437749-22-028558 | 5159 | ||||||
| 2022-12-06 | 4 | FORM 4 | 0001437749-22-028557 | 5147 | ||||||
| 2022-11-10 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-22-026924 | 001-35703 | 221377753 | 34 | 214409 | 1 | 1 |
| 2022-11-04 | 4 | FORM 4 | 0001437749-22-026041 | 4718 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001437749-22-026038 | 4626 | ||||||
| 2022-11-04 | 4 | FORM 4 | 0001437749-22-026032 | 4627 | ||||||
| 2022-11-03 | 10-Q | FORM 10-Q | 0001437749-22-025787 | 001-35703 | 221358739 | 34 | 8202468 | 1 | 1 | |
| 2022-11-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-22-025761 | 001-35703 | 221358097 | 34 | 374229 | 1 | 1 |
| 2022-10-05 | 4 | FORM 4 | 0001437749-22-023679 | 5156 | ||||||
| 2022-10-05 | 4 | FORM 4 | 0001437749-22-023677 | 5247 | ||||||
| 2022-10-05 | 4 | FORM 4 | 0001437749-22-023673 | 5155 | ||||||
| 2022-09-22 | 8-K | FORM 8-K | 1.01 | 0001437749-22-022922 | 001-35703 | 221259512 | 34 | 160250 | 1 | 1 |
| 2022-09-07 | 4 | FORM 4 | 0001437749-22-021986 | 5157 | ||||||
| 2022-09-07 | 4 | FORM 4 | 0001437749-22-021984 | 5248 | ||||||
| 2022-09-07 | 4 | FORM 4 | 0001437749-22-021980 | 5156 | ||||||
| 2022-08-10 | 4 | FORM 4 | 0001437749-22-019857 | 13467 | ||||||
| 2022-08-10 | 8-K | FORM 8-K | 7.01 | 0001437749-22-019800 | 001-35703 | 221152223 | 34 | 158512 | 1 | 1 |
| 2022-08-04 | 4 | FORM 4 | 0001437749-22-018993 | 4627 | ||||||
| 2022-08-04 | 4/A | FORM 4/A | 0001437749-22-018991 | 5704 | ||||||
| 2022-08-04 | 4 | FORM 4 | 0001437749-22-018960 | 4718 | ||||||
| 2022-08-04 | 4 | FORM 4 | 0001437749-22-018958 | 4626 | ||||||
| 2022-08-04 | 10-Q | FORM 10-Q | 0001437749-22-018920 | 001-35703 | 221137392 | 34 | 7484240 | 1 | 1 | |
| 2022-08-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-22-018894 | 001-35703 | 221136859 | 34 | 378575 | 1 | 1 |
| 2022-08-02 | 4 | FORM 4 | 0001437749-22-018468 | 5487 | ||||||
| 2022-08-02 | 3 | FORM 3 | 0001437749-22-018465 | 9573 | ||||||
| 2022-08-02 | 8-K | FORM 8-K | 5.02 | 0001437749-22-018452 | 001-35703 | 221129437 | 34 | 167961 | 1 | 1 |
| 2022-08-02 | 424B3 | FORM 424B3 | 0001437749-22-018442 | 333-266306 | 221129137 | 33 | 76596 | |||
| 2022-08-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-08-01 16:00:00 | 9999999995-22-002218 | 333-266306 | 221126735 | 33 | 1831 | ||
| 2022-07-28 | CORRESP | filename1.htm | 0001437749-22-017955 | 8828 | ||||||
| 2022-07-27 | UPLOAD | filename1.pdf | 0000000000-22-007906 | 40373 | ||||||
| 2022-07-25 | S-3 | pbyi20220718_s3.htm | 0001437749-22-017633 | 333-266306 | 221100673 | 33 | 402136 | |||
| 2022-07-08 | SC 13G | us74587v1070_070822.txt | 0000834237-22-010209 | 005-83367 | 221074937 | 34 | 12406 | |||
| 2022-07-07 | 4 | FORM 4 | 0001437749-22-016854 | 12340 | ||||||
| 2022-07-07 | 4 | FORM 4 | 0001437749-22-016852 | 5157 | ||||||
| 2022-07-07 | 4 | FORM 4 | 0001437749-22-016850 | 12251 | ||||||
| 2022-07-07 | 4 | FORM 4 | 0001437749-22-016848 | 12352 | ||||||
| 2022-07-07 | 4 | FORM 4 | 0001437749-22-016846 | 12180 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001437749-22-015538 | 4931 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001437749-22-015529 | 6293 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001437749-22-015527 | 4876 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001437749-22-015524 | 4700 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001437749-22-015296 | 4603 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001437749-22-015294 | 4423 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001437749-22-015292 | 4584 | ||||||
| 2022-06-17 | 8-K | FORM 8-K | 5.07 | 0001437749-22-015291 | 001-35703 | 221024048 | 34 | 176013 | 1 | 1 |
| 2022-06-16 | 4 | FORM 4 | 0001437749-22-015215 | 4548 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001437749-22-015212 | 4797 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001437749-22-015210 | 5966 | ||||||
| 2022-06-06 | 4 | FORM 4 | 0001437749-22-014437 | 4578 | ||||||
| 2022-06-06 | 4 | FORM 4 | 0001437749-22-014434 | 4590 | ||||||
| 2022-06-06 | 4 | FORM 4 | 0001437749-22-014432 | 4681 | ||||||
| 2022-06-06 | 4 | FORM 4 | 0001437749-22-014429 | 4627 | ||||||
| 2022-05-05 | 4 | FORM 4 | 0001437749-22-011162 | 4678 | ||||||
| 2022-05-05 | 10-Q | FORM 10-Q | 0001437749-22-011142 | 001-35703 | 22897219 | 34 | 6957563 | 1 | 1 | |
| 2022-05-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-22-011132 | 001-35703 | 22896468 | 34 | 302224 | 1 | 1 |
| 2022-05-04 | 4 | FORM 4 | 0001437749-22-010926 | 4587 | ||||||
| 2022-05-04 | 4 | FORM 4 AUERBACH | 0001437749-22-010922 | 4636 | ||||||
| 2022-04-29 | DEFA14A | FORM DEFA14A | 0001437749-22-010273 | 001-35703 | 22876335 | 34 | 443099 | |||
| 2022-04-29 | DEF 14A | FORM DEF 14A | 0001437749-22-010271 | 001-35703 | 22876232 | 34 | 2396467 | |||
| 2022-04-05 | 4 | FORM 4 | 0001437749-22-008339 | 4555 | ||||||
| 2022-04-05 | 4 | FORM 4 | 0001437749-22-008330 | 4609 | ||||||
| 2022-04-05 | 4 | FORM 4 | 0001437749-22-008328 | 4517 | ||||||
| 2022-03-17 | 4 | FORM 4 | 0001437749-22-006597 | 4981 | ||||||
| 2022-03-15 | 4 | FORM 4 | 0001437749-22-006268 | 7061 | ||||||
| 2022-03-15 | SC 13D/A | SCHEDULE 13D/A | 0001437749-22-006213 | 005-83367 | 22738512 | 34 | 263872 | |||
| 2022-03-14 | 4 | FORM 4 | 0001437749-22-006207 | 8779 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001437749-22-006190 | 7139 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001437749-22-006188 | 7047 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001437749-22-006180 | 7034 | ||||||
| 2022-03-14 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001437749-22-006127 | 001-35703 | 22736744 | 34 | 179016 | 1 | 1 |
| 2022-03-04 | 4 | FORM 4 | 0001437749-22-005306 | 4517 | ||||||
| 2022-03-04 | 4 | FORM 4 | 0001437749-22-005303 | 4610 | ||||||
| 2022-03-04 | 4 | FORM 4 | 0001437749-22-005301 | 4556 | ||||||
| 2022-03-03 | 10-K | FORM 10-K | 0001437749-22-005164 | 001-35703 | 22709728 | 34 | 9985719 | 1 | 1 | |
| 2022-03-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-22-005156 | 001-35703 | 22708873 | 34 | 380374 | 1 | 1 |
| 2022-02-14 | SC 13G/A | PRIMARY DOCUMENT | 0001654954-22-001583 | 005-83367 | 22626266 | 34 | 69527 | |||
| 2022-02-11 | SC 13G/A | e621313_sc13ga-puma.htm | 0001193805-22-000263 | 005-83367 | 22621366 | 34 | 97420 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018394 | 005-83367 | 22610653 | 34 | 13098 | |||
| 2022-02-10 | SC 13G/A | PUMA_BIOTECHNOLOGY_INC.txt | 0000093751-22-000059 | 005-83367 | 22609491 | 34 | 8488 | |||
| 2022-02-08 | SC 13G | PUMA BIOTECHNOLOGY, INC. | 0000769993-22-000139 | 005-83367 | 22602237 | 34 | 23690 | |||
| 2022-02-03 | 4 | FORM 4 | 0001437749-22-002423 | 4610 | ||||||
| 2022-02-03 | 4 | FORM 4 | 0001437749-22-002412 | 4518 | ||||||
| 2022-02-03 | 4 | FORM 4 | 0001437749-22-002408 | 4555 | ||||||
| 2022-02-03 | SC 13G/A | us74587v1070_020222.txt | 0000834237-22-005482 | 005-83367 | 22585734 | 34 | 13357 | |||
| 2022-01-14 | SC 13G | PBYI_SC13G_2022.htm | 0001273087-22-000007 | 005-83367 | 22531956 | 34 | 81568 | |||
| 2022-01-10 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-22-000622 | 001-35703 | 22519646 | 34 | 5880115 | 1 | 1 |
| 2022-01-05 | 4 | FORM 4 | 0001437749-22-000498 | 5056 | ||||||
| 2022-01-05 | 4 | FORM 4 | 0001437749-22-000465 | 5132 | ||||||
| 2022-01-05 | 4 | FORM 4 | 0001437749-22-000446 | 5078 | ||||||
| 2022-01-05 | 4 | FORM 4 | 0001437749-22-000444 | 5037 | ||||||
| 2021-12-14 | 8-K | FORM 8-K | 5.02 | 0001437749-21-028442 | 001-35703 | 211489207 | 34 | 155998 | 1 | 1 |
| 2021-12-06 | 4 | FORM 4 | 0001437749-21-027964 | 4609 | ||||||
| 2021-12-06 | 4 | FORM 4 - WONG | 0001437749-21-027956 | 4516 | ||||||
| 2021-12-06 | 4 | FORM 4 | 0001437749-21-027954 | 4517 | ||||||
| 2021-12-06 | 4 | FORM 4 AUERBACH | 0001437749-21-027952 | 4565 | ||||||
| 2021-11-19 | SC 13G | PBYI_SC13G_2021.htm | 0001319244-21-000262 | 005-83367 | 211428425 | 34 | 158224 | |||
| 2021-11-10 | SC 13G/A | PUMA BIOTECHNOLOGY, INC. | 0001193125-21-325976 | 005-83367 | 211396620 | 34 | 47374 | |||
| 2021-11-04 | 8-K | FORM 8-K | 1.01,9.01 | 0001437749-21-025336 | 001-35703 | 211381244 | 34 | 469726 | 1 | 1 |
| 2021-11-04 | 424B5 | FORM 424B5 | 0001437749-21-025332 | 333-257687 | 211381185 | 33 | 211090 | |||
| 2021-11-04 | 10-Q | FORM 10-Q | 0001437749-21-025298 | 001-35703 | 211380469 | 34 | 8855384 | 1 | 1 | |
| 2021-11-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-21-025291 | 001-35703 | 211380219 | 34 | 360882 | 1 | 1 |
| 2021-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-062788 | 4892 | ||||||
| 2021-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-062781 | 4963 | ||||||
| 2021-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-062777 | 4839 | ||||||
| 2021-10-06 | 4 | FORM 4 | 0001437749-21-023380 | 4520 | ||||||
| 2021-10-06 | 4 | FORM 4 | 0001437749-21-023377 | 4611 | ||||||
| 2021-10-06 | 4 | FORM 4 | 0001437749-21-023375 | 4558 | ||||||
| 2021-09-16 | S-8 | S-8 | 0001193125-21-275112 | 333-259585 | 211258021 | 33 | 121099 | |||
| 2021-09-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-054951 | 4963 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054918 | 5361 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054896 | 4892 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001564590-21-041634 | 001-35703 | 211148831 | 34 | 11702570 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-237729 | 001-35703 | 211148435 | 34 | 277869 | 1 | 1 |
| 2021-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-049435 | 4893 | ||||||
| 2021-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-049429 | 4964 | ||||||
| 2021-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-049423 | 4839 | ||||||
| 2021-07-29 | 8-K | 8-K | 1.01,2.03 | 0001193125-21-229184 | 001-35703 | 211127435 | 34 | 153761 | 1 | 1 |
| 2021-07-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-046945 | 5825 | ||||||
| 2021-07-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-046942 | 3030 | ||||||
| 2021-07-14 | 8-K | 8-K | 5.02 | 0001193125-21-215227 | 001-35703 | 211090293 | 34 | 148725 | 1 | 1 |
| 2021-07-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-07-13 09:00:00 | 9999999995-21-002747 | 333-257687 | 211089208 | 33 | 1831 | ||
| 2021-07-08 | CORRESP | filename1.htm | 0001193125-21-211030 | 7800 | ||||||
| 2021-07-08 | UPLOAD | filename1.pdf | 0000000000-21-008453 | 40327 | ||||||
| 2021-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-045683 | 5360 | ||||||
| 2021-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-045599 | 4893 | ||||||
| 2021-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-045596 | 5486 | ||||||
| 2021-07-02 | S-3 | S-3 | 0001193125-21-207767 | 333-257687 | 211071506 | 33 | 140271 | |||
| 2021-06-25 | 8-K | 8-K | 8.01 | 0001193125-21-198985 | 001-35703 | 211044225 | 34 | 144051 | 1 | 1 |
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-042589 | 5759 | ||||||
| 2021-06-22 | 3 | FORM 3 SUBMISSION | 0001209191-21-042585 | 12527 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041803 | 6335 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041787 | 4975 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041781 | 4975 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041779 | 4920 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041731 | 5175 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041706 | 4795 | ||||||
| 2021-06-17 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-192345 | 001-35703 | 211022862 | 34 | 203753 | 1 | 1 |
| 2021-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-040710 | 5157 |
One latest value per concept from companyfacts (408 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 51.70M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 145.20M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | pure | 204.07M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.40M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.26M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 125 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 4.43M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 3.06M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 58 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001437749-26-013671 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccountsPayableCurrentAndNoncurrent | Accounts Payable | USD | 3,280 | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-15 | 0001144204-11-047512 | |
| us-gaap | AccountsReceivableGross | Accounts Receivable, before Allowance for Credit Loss | USD | 32.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 53.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 32.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 5.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 45.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 50.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | AccruedPayrollTaxesCurrent | Accrued Payroll Taxes, Current | USD | 16.41M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-29 | 0001564590-16-013716 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 195,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 8.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccumulatedAmortizationDeferredFinanceCosts | Accumulated Amortization, Debt Issuance Costs | USD | 5.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 2.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -98,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.42B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AdjustmentOfWarrantsGrantedForServices | Adjustment of Warrants Granted for Services | USD | 18.22M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 61,000 | 2011-01-01 | 2011-12-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 200,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 18.22M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 5.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableRecoveries | Accounts Receivable, Allowance for Credit Loss, Recovery | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 1.30M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 7.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | AmortizationOfLeaseIncentives | Amortization of Lease Incentives | USD | 3.00M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 3.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | Assets | Assets | USD | 202.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 157.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 98,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 79.83M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 112.84M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 4,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-10 | 0001564590-17-010232 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 3,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 112.85M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 79.83M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001437749-26-026311 |
| us-gaap | CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent | Capital Leases, Lessor Balance Sheet, Net Investment in Direct Financing and Sales Type Leases, Current | USD | 17.34M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-09 | 0001193125-13-211141 | |
| us-gaap | Cash | Cash | USD | 13.90M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 41.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -3.15M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 100.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 72.62M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 41.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 9.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 67.80M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 | |
| us-gaap | CashPeriodIncreaseDecrease | Cash, Period Increase (Decrease) | USD | 25,467 | 2010-09-15 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311276 |
| us-gaap | CashUninsuredAmount | Cash, Uninsured Amount | USD | 86.70M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-09 | 0001564590-18-005152 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Right | 0.01 | 2011-10-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 2.12M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 51.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 51.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 10.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 67.22M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 38.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 6.38M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | CostOfReimbursableExpense | Cost of Reimbursable Expense (Deprecated 2018-01-31) | USD | 16.40M | 2013-01-01 | 2013-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001564590-17-003090 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 147.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 207,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 179,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 598,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 1.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 150,000 | 2010-10-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 102.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001437749-26-026311 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 3.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 8.67M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 3.92M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 3.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 3.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 1.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredRentAssetNetCurrent | Deferred Rent Asset, Net, Current | USD | 195,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 5.82M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 193,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | DeferredTaxAssetInterestCarryforward | Deferred Tax Asset, Interest Carryforward | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 329.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 3.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 5.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 230.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 5.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 14.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 13.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 217,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 139,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 1.40M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 324.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts | Deferred Tax Liabilities, Inventory | USD | 21,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 1.36M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 2,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-04-01 | 0001193125-13-136650 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 1.70M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001193125-13-438277 | |
| us-gaap | Depreciation | Depreciation | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 7.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 233.73M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.2 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.52 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 0.2 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.131 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.521 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.409 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 4.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.035 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.036 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 33.80M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 | |
| us-gaap | EquityIssuanceDollarAmountPerShare | Equity Issuance, Amount Per Share (Deprecated 2012-01-31) | USD | 0 | 2010-12-31 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311276 | |
| us-gaap | EquityIssuancePerShareAmount | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | USD | 190 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003915 |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 1 | 2011-10-04 | 2017 | FY | 10-K | 2018-03-09 | 0001564590-18-005152 | |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 102.00M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001437749-26-026311 |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 18.20M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 68.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 2.44M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 9.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 2.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 2.44M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 2.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 9.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 9.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 41.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | FiniteLivedLicenseAgreementsGross | Finite-Lived License Agreements, Gross | USD | 102.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 848,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -368,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | -1.18M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | GainsLossesOnRestructuringOfDebt | Gains (Losses) on Restructuring of Debt | USD | -289,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 18.40M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-10 | 0001564590-17-010232 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001564590-17-003090 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 35.78M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 10.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.72 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 897,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 4.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 179,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 1.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -18.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 141.15M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 179,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 7.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 12.95M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 243,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 14.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 20,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | -20,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 1.70M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.28M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.53M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 26.66M | 2010-09-15 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001193125-12-469037 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -20.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 155,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037821 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -4.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInContractReceivablesNet | Increase (Decrease) in Contract Receivables, Net | USD | -1.76M | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001564590-17-003090 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 7.08M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | IncreaseDecreaseInDeferredLeasingFees | Increase (Decrease) in Deferred Leasing Fees | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | 9,897 | 2010-09-15 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311276 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 5.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -82,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -1.76M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-09 | 0001564590-18-005152 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 953,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | 1.18M | 2016-01-01 | 2016-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001564590-17-016942 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | -1,000 | 2017-01-01 | 2017-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-021046 |
| us-gaap | InsuranceSettlementsReceivableCurrent | Insurance Settlements Receivable, Current | USD | 1.18M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 | |
| us-gaap | IntangibleAssetsNetIncludingGoodwill | Intangible Assets, Net (Including Goodwill) | USD | 34.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | InterestExpense | Interest Expense | USD | 3.36M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-02 | 0001437749-24-014395 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 911,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 989,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 760,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 869,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 11.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 7.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 3.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 1.22M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001564590-15-001193 | |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.124 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 6.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 951,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 951,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 304,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 81,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedFiveYears | Lessor, Operating Lease, Payment to be Received, Year Five | USD | 133,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedFourYears | Lessor, Operating Lease, Payment to be Received, Year Four | USD | 134,000 | 2023-03-31 | 2022 | Q1 | 10-Q | 2023-05-04 | 0001437749-23-012589 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 81,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear | Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year | USD | 132,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001437749-25-033633 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThereafter | Lessor, Operating Lease, Payment to be Received, after Year Five | USD | 133,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 266,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 132,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 150,000 | 2012-06-07 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001193125-12-469037 | |
| us-gaap | Liabilities | Liabilities | USD | 56.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 202.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 51.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 30.50M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 11.34M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001437749-26-015633 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 11.34M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001437749-26-015633 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 22.67M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 22.67M | 2023-03-31 | 2022 | Q1 | 10-Q | 2023-05-04 | 0001437749-23-012589 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 22.67M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 22.67M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 11.33M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001437749-25-033633 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001437749-26-026311 | |
| us-gaap | LossContingencyAccrualProvision | Loss Contingency Accrual, Provision | USD | 2.00M | 2021-07-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 67.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -22.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 3.15M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 732,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -40,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 31.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -6.25M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 10.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -59.99M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 | Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued | shares | 18.67M | 2011-09-01 | 2011-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | NontradeReceivablesNoncurrent | Nontrade Receivables, Noncurrent | USD | 1.76M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003915 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 150,000 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001193125-11-311276 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001437749-25-033633 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 148.14M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 9.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001437749-23-030028 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 4.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 683,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 4.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 39.76M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 4.92M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 5.63M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 5.46M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 5.30M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 5.14M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 13.30M | 2018-12-31 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 4.70M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.124 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 219,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 174,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OtherAssetsMiscellaneousCurrent | Other Assets, Miscellaneous, Current | USD | 509,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -2,000 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0001437749-22-025787 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -134,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OtherExpenses | Other Expenses | USD | 80,000 | 2011-01-01 | 2011-12-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -179,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001564590-15-006819 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 158,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 1.76M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-29 | 0001564590-16-013716 | |
| us-gaap | PaymentsForCapitalImprovements | Payments for Capital Improvements | USD | 170,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | PaymentsForMergerRelatedCosts | Payments for Merger Related Costs | USD | 40,000 | 2011-09-01 | 2011-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | PaymentsForProceedsFromProductiveAssets | Payments for (Proceeds from) Productive Assets | USD | 435,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003915 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 40,000 | 2011-09-01 | 2011-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 445,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 71.11M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 82.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 44.38M | 2010-09-16 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001193125-13-438277 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-09 | 0001564590-18-005152 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-09 | 0001564590-18-005152 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-15 | 0001144204-11-047512 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-15 | 0001144204-11-047512 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-15 | 0001144204-11-047512 | |
| us-gaap | PrepaidExpenseAndOtherAssets | Prepaid Expense and Other Assets | USD | 7.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 11.28M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 2.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 4.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PrepaidExpenseOtherNoncurrent | Prepaid Expense Other, Noncurrent | USD | 2.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 219,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 417,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 68,000 | 2010-10-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 161.85M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006121 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 25.00M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-28 | 0001564590-20-007591 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 83.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 150,000 | 2010-10-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 94.60M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001564590-19-031182 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 7.15M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-05 | 0001564590-18-026644 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 146,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 11.32M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 84,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock | Receivable from Shareholders or Affiliates for Issuance of Capital Stock | USD | 11,000 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-10 | 0001564590-19-018584 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 1.18M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028617 | |
| us-gaap | ReimbursementRevenue | Reimbursement Revenue (Deprecated 2018-01-31) | USD | 1.80M | 2015-06-01 | 2015-06-30 | 2015 | Q3 | 10-Q | 2015-11-09 | 0001564590-15-010147 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 22.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 27.20M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001437749-22-018920 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 56.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 7.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0001437749-23-005233 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 157,000 | 2012-06-07 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001193125-12-469037 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 1.22M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003915 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 13.17M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041793 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.27B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 156.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | Revenues | Revenues | USD | 66.52M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001437749-26-015633 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 7.90M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-09 | 0001193125-13-211141 |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 36.02M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-013008 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 52.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 0 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 0 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 9,469 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 102.46 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 471,181 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001437749-26-015633 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001564590-16-023661 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2021-06-15 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.87 | 2021-06-15 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.008 | 2021-06-15 | 2021 | Q2 | 10-Q | 2021-08-05 | 0001564590-21-041634 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1.08M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 3.81M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 76.21 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 119,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 744,256 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 105,646 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 270,500 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001564590-15-003915 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 441,430 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.37 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 438,947 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 128,406 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 4.17 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 4.02 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1.08M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 4.76M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 63.13 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 603,817 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 3.75 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033955 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 3.75 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009840 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 84.47 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.16 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 11.12 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | SharePrice | Share Price | USD/shares | 16 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 40 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 146.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 | |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationGross | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture | shares | 1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 50,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 146,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 0 | 2010-09-16 | 2010-12-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001564590-14-005392 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 12.22M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001437749-25-005496 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 576,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 94.93M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-29 | 0001564590-16-013716 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 0 | 2026-04-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 1.20M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028617 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 3.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 50,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001564590-17-003090 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 403,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 205,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 8.80M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001564590-19-005830 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -18.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001437749-26-005891 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 300,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001437749-21-025298 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 25.80M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-03 | 0001193125-14-080183 | |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 1.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 52.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 40.64M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-03 | 0001437749-22-005164 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 51.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001437749-26-035912 |